Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma

Published:2014-06-02 Issue:5 Volume:2 Page:773-782
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:en
Short-container-title:

Author:

SCHMITT MICHAEL,TRENSCHEL RUDOLF,SAYER HERBERT G.,SCHNEIDER CATARINA,GLASS AENNE,HILGENDORF INKEN,TRESCHL ANNE,JUNGHANSS CHRISTIAN,BORCHERT KERSTEN,KOENIGSMANN MICHAEL,CASPER JOCHEN,BEELEN DIETRICH W.,FREUND MATHIAS,KAHL CHRISTOPH

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis;International Journal of Hematology;2023-11-12

2. Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma;Bone Marrow Transplantation;2022-05-10

3. SINGLE-CENTER EXPERIENCE IN RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMA (RELAPS/REFRAKTER NON HODGKİN LENFOMALARDA TEK MERKEZ DENEYİMİ);Cumhuriyet Medical Journal;2022-03-24

4. Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens;Pediatric Hematology and Oncology;2020-03-13

5. Treosulfan in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation;Drugs of Today;2020